Popular Articles

Connecticut House Approves Two Health Insurance Pooling Bills
The Connecticut House on Wednesday approved two separate measures to expand health insurance pooling in the state, the Hartford Courant reports. The first measure would create a public health insurance pool open to all residents. The pool, intended to compete with rather than replace private insurance, would be based on the existing pool for state workers (Keating, Hartford Courant, 5/21). The bill will create a nine-member board of directors to investigate and recommend a plan to guarantee every resident health insurance. The bill also creates four committees that will work with the board and provide advice on electronic health records, medical homes, clinical care guidelines and preventive care. In addition, three task forces will examine obesity, tobacco use and care provider shortages (Stuart, CT News Junkie, 5/20).The cost of plan, known as SustiNet, could be a "sticking point" given the state"s $8.7 billion budget deficit over the next two years, the Courant reports The state Senate and Gov. Jodi Rell (R) will consider the plan next.The second measure would allow local governments, small businesses and not-for-profit groups join the state employee insurance plan. The bill would increase the current pool"s membership from 200,000 to an estimated 300,000. Juan Figueroa, a former state legislator and president of the Universal Health Care Foundation of Connecticut, said, "Both of these plans reduce costs and increase choice. The partnership (pooling) bill has features that SustiNet can build on. The two bills fit hand in glove." Democrats said the second bill would utilize economies of scale to lower costs. Steve Fontana (D), co-chair of the State House Insurance and Real Estate Committee, said, "The larger the pool you have, ... you reduce the volatility and the risk associated with that pool."Opponents say the pooling measure would affect only those who already have coverage. According to House Republican Leader Larry Cafero, "This bill does not solve that problem. If you don"t have it now, you"re not going to have it because of this" (Keating, Hartford Courant, 5/21).

Tibotec, TB Alliance Join To Expedite Development Of Promising TB Drug
The pharmaceutical company Tibotec said it will join with the non-profit Global Alliance for Tuberculosis Development (TB Alliance) to speed up the development of the experimental TB drug TMC207, Health-e/IOL reports (Thom, Health-e/IOL, 6/18). Tibotec, which is a subsidiary of Johnson & Johnson, announced the news on Wednesday at the Pacific Health Summit in Seattle (Doughton, Seattle Times, 6/18).
News of the day
Study Reveals Prevalence Of Disordered Eating In Patients With Anxiety
Doctors and other health workers should be more aware of the high risk of eating disorders among people with obsessive compulsive disorder (OCD) and other anxiety disorders.
Medical Devices

More Women Seek Nonprescription Remedies For Menopause Symptoms

Over-the-counter remedies for menopause symptoms are growing in popularity among some women who fear potential risks from prescription hormone replacement therapy, the New York Times reports. According to the Times, the market for alternative therapies -- such as natural supplements and topical creams -- jumped in 2002 after initial results from the Women"s Health Initiative suggested that HRT could increase risk for heart disease, cancer, stroke and blood clots. Gynecologists estimate that about one-third of menopausal women are treated with conventional prescription hormones, and about one-third are treated with bio-identical hormones -- plant-derived synthetic hormones that mimic the molecular structure of human hormones. The remaining one-third either do not seek therapy for symptoms, are not bothered by symptoms or use over-the-counter therapies. There are more than 500 over-the-counter products available that claim to alleviate menopause symptoms, the Times reports. The treatments include such products as teas, low-dose progesterone creams, black cohosh capsules and phytoestrogens derived from soy and red clover, according to the Times. According to Nutrition Business Journal, the U.S. dietary supplement market associated with menopause increased from $211 million in 1999 to $337 million in 2007.Some studies have raised doubts about the safety and effectiveness of the over-the-counter remedies. Todd Cooperman -- director of consumerLab.com, a private nutrition product-testing lab -- said that his company"s study of more than one dozen products found that five failed to gain the lab"s approval because of problems such as inaccurate labeling or tainted ingredients. The Center for Botanical Dietary Supplements Research this fall is expected to release the results of a study, sponsored by the National Institutes of Health, that aims to determine the efficacy of the ingredients associated with menopause symptom relief. Some studies have questioned the efficacy of progesterone creams, which some experts contend can gather in fat cells and disrupt the production and synthesis of other hormones. Other experts maintain that the products are safe if properly used. Theresa Ramsey, director of the Center for Natural Healing in Arizona, said, "I think over all these products are generally safe, but must be taken in the right circumstances and in conjunction with a mindfully healthy approach to life if they are going to be effective at all" (Sweeney, New York Times, 7/2). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):